Original Article
Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting
Estudo de custo-efectividade de rivaroxabano para prevenção de acidente vascular cerebral em doentes com fibrilhação auricular em Portugal
Lido
9741
Vezesque se leu este artigo
2300
Total PDF
7441
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 22 | 8 | 30 |
| 2025 5 | 123 | 27 | 150 |
| 2025 4 | 100 | 30 | 130 |
| 2025 3 | 97 | 26 | 123 |
| 2025 2 | 89 | 23 | 112 |
| 2025 1 | 56 | 34 | 90 |
| 2024 12 | 52 | 24 | 76 |
| 2024 11 | 77 | 43 | 120 |
| 2024 10 | 58 | 20 | 78 |
| 2024 9 | 98 | 26 | 124 |
| 2024 8 | 67 | 27 | 94 |
| 2024 7 | 38 | 32 | 70 |
| 2024 6 | 54 | 22 | 76 |
| 2024 5 | 57 | 24 | 81 |
| 2024 4 | 57 | 30 | 87 |
| 2024 3 | 60 | 18 | 78 |
| 2024 2 | 38 | 20 | 58 |
| 2024 1 | 34 | 25 | 59 |
| 2023 12 | 31 | 36 | 67 |
| 2023 11 | 40 | 22 | 62 |
| 2023 10 | 28 | 13 | 41 |
| 2023 9 | 34 | 18 | 52 |
| 2023 8 | 42 | 20 | 62 |
| 2023 7 | 28 | 10 | 38 |
| 2023 6 | 36 | 10 | 46 |
| 2023 5 | 42 | 22 | 64 |
| 2023 4 | 32 | 3 | 35 |
| 2023 3 | 61 | 21 | 82 |
| 2023 2 | 38 | 18 | 56 |
| 2023 1 | 45 | 14 | 59 |
| 2022 12 | 55 | 22 | 77 |
| 2022 11 | 79 | 23 | 102 |
| 2022 10 | 42 | 26 | 68 |
| 2022 9 | 34 | 34 | 68 |
| 2022 8 | 40 | 25 | 65 |
| 2022 7 | 70 | 45 | 115 |
| 2022 6 | 76 | 25 | 101 |
| 2022 5 | 50 | 26 | 76 |
| 2022 4 | 57 | 29 | 86 |
| 2022 3 | 47 | 37 | 84 |
| 2022 2 | 44 | 16 | 60 |
| 2021 1 | 42 | 26 | 68 |
| 2021 12 | 24 | 40 | 64 |
| 2021 11 | 46 | 36 | 82 |
| 2021 10 | 34 | 42 | 76 |
| 2021 9 | 28 | 29 | 57 |
| 2021 8 | 32 | 25 | 57 |
| 2021 7 | 17 | 24 | 41 |
| 2021 6 | 24 | 26 | 50 |
| 2021 5 | 23 | 28 | 51 |
| 2021 4 | 68 | 47 | 115 |
| 2021 3 | 68 | 25 | 93 |
| 2021 2 | 52 | 21 | 73 |
| 2020 1 | 48 | 12 | 60 |
| 2020 12 | 31 | 13 | 44 |
| 2020 11 | 36 | 18 | 54 |
| 2020 10 | 28 | 18 | 46 |
| 2020 9 | 55 | 9 | 64 |
| 2020 8 | 33 | 15 | 48 |
| 2020 7 | 58 | 11 | 69 |
| 2020 6 | 52 | 8 | 60 |
| 2020 5 | 85 | 8 | 93 |
| 2020 4 | 72 | 13 | 85 |
| 2020 3 | 60 | 12 | 72 |
| 2020 2 | 91 | 23 | 114 |
| 2020 1 | 31 | 4 | 35 |
| 2019 12 | 43 | 6 | 49 |
| 2019 11 | 44 | 11 | 55 |
| 2019 10 | 33 | 6 | 39 |
| 2019 9 | 99 | 7 | 106 |
| 2019 8 | 35 | 8 | 43 |
| 2019 7 | 34 | 12 | 46 |
| 2019 6 | 40 | 16 | 56 |
| 2019 5 | 44 | 9 | 53 |
| 2019 4 | 40 | 16 | 56 |
| 2019 3 | 119 | 11 | 130 |
| 2019 2 | 66 | 8 | 74 |
| 2019 1 | 60 | 8 | 68 |
| 2018 12 | 78 | 12 | 90 |
| 2018 11 | 171 | 17 | 188 |
| 2018 10 | 572 | 14 | 586 |
| 2018 9 | 74 | 12 | 86 |
| 2018 8 | 46 | 12 | 58 |
| 2018 7 | 43 | 7 | 50 |
| 2018 6 | 60 | 5 | 65 |
| 2018 5 | 62 | 14 | 76 |
| 2018 4 | 136 | 8 | 144 |
| 2018 3 | 53 | 10 | 63 |
| 2018 2 | 45 | 2 | 47 |
| 2018 1 | 42 | 11 | 53 |
| 2017 12 | 76 | 12 | 88 |
| 2017 11 | 40 | 8 | 48 |
| 2017 10 | 30 | 11 | 41 |
| 2017 9 | 43 | 11 | 54 |
| 2017 8 | 36 | 8 | 44 |
| 2017 7 | 31 | 6 | 37 |
| 2017 6 | 52 | 13 | 65 |
| 2017 5 | 37 | 15 | 52 |
| 2017 4 | 44 | 5 | 49 |
| 2017 3 | 37 | 4 | 41 |
| 2017 2 | 36 | 5 | 41 |
| 2017 1 | 41 | 5 | 46 |
| 2016 12 | 23 | 12 | 35 |
| 2016 11 | 26 | 13 | 39 |
| 2016 10 | 17 | 6 | 23 |
| 2016 9 | 70 | 8 | 78 |
| 2016 8 | 190 | 0 | 190 |
| 2016 7 | 23 | 2 | 25 |
| 2016 6 | 11 | 4 | 15 |
| 2016 5 | 6 | 6 | 12 |
| 2016 4 | 46 | 5 | 51 |
| 2016 3 | 56 | 18 | 74 |
| 2016 2 | 82 | 25 | 107 |
| 2015 1 | 54 | 15 | 69 |
| 2015 12 | 67 | 15 | 82 |
| 2015 11 | 59 | 17 | 76 |
| 2015 10 | 68 | 26 | 94 |
| 2015 9 | 64 | 24 | 88 |
| 2015 8 | 41 | 10 | 51 |
| 2015 7 | 54 | 5 | 59 |
| 2015 6 | 45 | 8 | 53 |
| 2015 5 | 58 | 12 | 70 |
| 2015 4 | 57 | 24 | 81 |
| 2015 3 | 52 | 15 | 67 |
| 2015 2 | 47 | 12 | 59 |
| 2014 1 | 36 | 18 | 54 |
| 2014 12 | 55 | 21 | 76 |
| 2014 11 | 103 | 22 | 125 |
| 2014 10 | 123 | 105 | 228 |
Mostrar tudo
